[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100584078":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":26,"centralContacts":30,"locations":36,"responsibleParty":46,"collaborators":26,"id":50,"slug":51,"hasResults":52,"nctId":53,"briefTitle":54,"officialTitle":55,"acronym":56,"eligibilityCriteria":57,"healthyVolunteers":52,"sex":58,"minAge":59,"maxAge":60,"enrollmentInfo":61,"targetDuration":26,"studyType":64,"phases":65,"briefSummary":67,"conditions":68,"keywords":26,"overallStatus":39,"whyStopped":26,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":74,"completionDateStruct":76,"leadSponsor":78,"locationsCount":79},{"fullName":5,"class":6},"Cukurova University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Mannitol","ACTIVE_COMPARATOR","2.5 ml\u002Fkg (0.5 g\u002Fkg) Mannitol will be given to all patients 15 minutes after induction and the mannitol infusion will be adjusted to be 10 minutes.",[13],"Drug: mannitol",{"label":15,"type":16,"description":17,"interventionNames":18},"Saline","PLACEBO_COMPARATOR","2.5 ml\u002Fkg saline will be given to patients 15 minutes after induction and the infusion will be adjusted to be 10 minutes.",[19],"Other: Saline",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DRUG","mannitol","2.5 mg\u002Fkg Mannitol will be given intravenously",[9],null,{"type":6,"name":15,"description":28,"armGroupLabels":29,"otherNames":26},"2.5 ml\u002Fkg saline will be given as plasebo",[15],[31],{"name":32,"role":33,"phone":34,"phoneExt":26,"email":35},"Ebru Biricik","CONTACT","+905052420223","ebrubiricik01@gmail.com",[37],{"facility":38,"status":39,"city":40,"state":41,"zip":26,"country":42,"countryCode":26,"cosmosGeoPoint":26,"geoPoint":26,"contacts":43},"Çukurova University","RECRUITING","Çukurova","Adana","Turkey (Türkiye)",[44],{"name":32,"role":33,"phone":45,"phoneExt":26,"email":35},"05052420223",{"type":47,"investigatorFullName":48,"investigatorTitle":49,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"PRINCIPAL_INVESTIGATOR","ebru biricik","associate professor","100584078","phase-4-effect-of-mannitol-on-propofol-level-100584078",false,"NCT06884657","Effect of Mannitol on Propofol Level","Propofol Level at TCI During Mannitol","level","Inclusion Criteria:\n\n* American Society of Anesthesiologist (ASA) II participants\n* supratentorial tumor surgery\n* eligible for mannitol use\n* eligible for Total intravenous anesthesia (TIVA)\n\nExclusion Criteria:\n\n* American Society of Anesthesiologist (ASA) III and upper\n* Chronic kidney failure\n* sepsis\n* multiorgan failure","ALL","18 Years","65 Years",{"count":62,"type":63},40,"ESTIMATED","INTERVENTIONAL",[66],"PHASE4","Group 1 will include 20 patients aged 18 years and over, American Society of Anesthesiologist (ASA) II-III class, who will undergo supratentorial tumor surgery, and Group 2 will include 20 patients who will undergo pituitary surgery without mannitol. Total intravenous anesthesia (TIVA) will be adjusted to propofol 4 µg\u002Fdl and remifentanil 2-4 µg\u002Fdl with target-controlled infusion pumps. In the mannitol group, 2.5 ml\u002Fkg (0.5 g\u002Fkg) will be given to all patients 20 minutes after induction and the mannitol infusion will be adjusted to be 10 minutes.In Group 2, mannitol will not be used and 2.5 ml\u002Fkg isotonic will be administered in 10 minutes. Both blood and urine samples will take for measurement to propofol levels.",[69],"Mannitol Adverse Reaction","2025-08-25",{"date":72,"type":73},"2025-09-02","ACTUAL",{"date":75,"type":73},"2025-03-20",{"date":77,"type":63},"2025-10-30",{"name":5,"class":6},1]